81. Treating KRAS-mutant NSCLC: latest evidence and clinical consequences. (September 2017) Authors: Garrido, Pilar; Olmedo, María Eugenia; Gómez, Ana; Paz Ares, Luis; López-Ríos, Fernando; Rosa-Rosa, Juan Manuel; Palacios, José Journal: Therapeutic advances in medical oncology Issue: Volume 9:Number 9(2017) Page Start: 589 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
82. Ultrasensitive bioanalysis: current status and future trends. (May 2017) Authors: Simon, Stéphanie; Ezan, Eric Journal: Bioanalysis Issue: Volume 9:Number 9(2017) Page Start: 753 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
83. Unique aspects of the epigenetic code in the brain. (September 2017) Authors: Zawia, Nasser H Journal: Epigenomics Issue: Volume 9:Number 9(2017) Page Start: 1157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
84. Verapamil eluting stents as a possible treatment for vasospasm after subarachnoid hemorrhage. (29th July 2016) Authors: Bhambri, Pallavi; Sarvi, Ali; Wong, John H; Sundararaj, Uttandaraman; Mitha, Alim P Journal: Journal of neurointerventional surgery Issue: Volume 9:Number 9(2017) Page Start: 875 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
85. What structural modifications can be used for BRD4 inhibitors for their use in leukemia therapy?. (June 2017) Authors: Yao, Dahong; Liu, Jie; Ouyang, Liang Journal: Future medicinal chemistry Issue: Volume 9:Number 9(2017) Page Start: 839 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗